InvestorsHub Logo
Followers 4
Posts 702
Boards Moderated 0
Alias Born 05/19/2016

Re: XenaLives post# 122668

Saturday, 09/30/2017 1:58:17 PM

Saturday, September 30, 2017 1:58:17 PM

Post# of 470267
I don't think we will see that for a couple reasons.

It is a short term study to begin with, followed by the option for anyone in the trial (including placebo patients) to continue with 2-73 treatment if they desire.

The trial protocols are already decided and did not mention any crossing over.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News